Your browser doesn't support javascript.
loading
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.
Ciardiello, F; Normanno, N; Martinelli, E; Troiani, T; Pisconti, S; Cardone, C; Nappi, A; Bordonaro, A R; Rachiglio, M; Lambiase, M; Latiano, T P; Modoni, G; Cordio, S; Giuliani, F; Biglietto, M; Montesarchio, V; Barone, C; Tonini, G; Cinieri, S; Febbraro, A; Rizzi, D; De Vita, F; Orditura, M; Colucci, G; Maiello, E.
Afiliação
  • Ciardiello F; Medical Oncology, Department of Clinical and Experimental Medicine 'F. Magrassi', Second University of Naples, Naples. Electronic address: fortunato.ciardiello@unina2.it.
  • Normanno N; Cell Biology and Biotherapy Unit, National Cancer Institute 'Fondazione Giovanni Pascale', Naples.
  • Martinelli E; Medical Oncology, Department of Clinical and Experimental Medicine 'F. Magrassi', Second University of Naples, Naples.
  • Troiani T; Medical Oncology, Department of Clinical and Experimental Medicine 'F. Magrassi', Second University of Naples, Naples.
  • Pisconti S; Medical Oncology, Hospital SS. Annunziata, Taranto.
  • Cardone C; Medical Oncology, Department of Clinical and Experimental Medicine 'F. Magrassi', Second University of Naples, Naples.
  • Nappi A; Medical Oncology, Department of Clinical and Experimental Medicine 'F. Magrassi', Second University of Naples, Naples.
  • Bordonaro AR; Medical Oncology, Hospital Garibaldi, Nesima, Catania.
  • Rachiglio M; Cell Biology and Biotherapy Unit, National Cancer Institute 'Fondazione Giovanni Pascale', Naples; Laboratory of Pharmacogenomics, Centro di Ricerche Oncologiche di Mercogliano (CROM)-National Cancer Institute 'Fondazione Giovanni Pascale', Naples.
  • Lambiase M; Cell Biology and Biotherapy Unit, National Cancer Institute 'Fondazione Giovanni Pascale', Naples; Laboratory of Pharmacogenomics, Centro di Ricerche Oncologiche di Mercogliano (CROM)-National Cancer Institute 'Fondazione Giovanni Pascale', Naples.
  • Latiano TP; Medical Oncology, Hospital Casa Sollievo della Sofferenza, San Giovanni Rotondo (Foggia).
  • Modoni G; Medical Oncology, Hospital SS. Annunziata, Taranto.
  • Cordio S; Medical Oncology, Hospital Garibaldi, Nesima, Catania.
  • Giuliani F; Medical Oncology, National Cancer Institute Giovanni Paolo II, Bari.
  • Biglietto M; Medical Oncology, Hospital 'A. Cardarelli', Naples.
  • Montesarchio V; Medical Oncology, Hospital Monaldi- Azienda Ospedaliera dei Colli, Naples.
  • Barone C; Medical Oncology, University Hospital A. Gemelli, Rome.
  • Tonini G; Policlinico Universitario Campus Bio-Medico, Rome.
  • Cinieri S; Medical Oncology, Hospital A. Perrino, Brindisi.
  • Febbraro A; Medical Oncology, Hospital Sacro Cuore di Gesù, Fatebenefratelli, Benevento.
  • Rizzi D; GOIM Trial Office, Bari, Italy.
  • De Vita F; Medical Oncology, Department of Clinical and Experimental Medicine 'F. Magrassi', Second University of Naples, Naples.
  • Orditura M; Medical Oncology, Department of Clinical and Experimental Medicine 'F. Magrassi', Second University of Naples, Naples.
  • Colucci G; Medical Oncology, National Cancer Institute Giovanni Paolo II, Bari.
  • Maiello E; Medical Oncology, Hospital Casa Sollievo della Sofferenza, San Giovanni Rotondo (Foggia).
Ann Oncol ; 27(6): 1055-1061, 2016 06.
Article em En | MEDLINE | ID: mdl-27002107
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article